LRA Forum for Discovery Showcases Cutting-Edge Lupus Research
The Lupus Research Alliance (LRA) hosted its highly anticipated annual scientific conference, Forum for Discovery (FFD), November 11-13 in...
UCB
Lupus Therapeutics Statement on Positive Data from Phase 3 PHOENYCS GO Trial in Moderate-To-Severe Systemic Lupus
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance (LRA), is encouraged by the positive Phase 3...
Investigational Treatment Dapirolizumab Pegol Shows Positive Results in Phase 3 Clinical Trial
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud to share positive topline results from...
Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments
November 14, 2019
The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly...